Two SCLC cell models of H82 and H524 cells with variable basal levels of STING (as examined by western blot and RT-PCR for protein and gene expression) were selected to perform sequential in vitro treatment with cisplatin and RT at the indicated doses. This evidence concerns the gene STING1 and small cell lung carcinoma.